Vaccinations: More than just kid stuff
Follow me on Twitter @RobShmerling This is the time of year when it’s important to think about flu vaccinations. And there’s good reason for that! The flu causes thousands of preventable hospitalizations and deaths each year. But what about other vaccinations? Do you think of them as something for kids? You aren’t alone. And it’s true, a number of vaccinations are recommended for young children as well as preteens and teenagers. These vaccinations have provided an enormous benefit to public health by preventing diseases that were common and sometimes deadly in the past, including polio, rubella, and whooping cough. But there are several vaccinations recommended for healthy adults as well. And over time, these recommendations change. Here is a quick rundown. Vaccinations for adults According to the CDC, adults should consider receiving vaccinations to prevent influenza (during the fall and winter) tetanus a certain type of bacterial pneumonia (called pneumococcal pneumonia) shingles In addition, adults should have vaccinations to prevent a number of infections if they were not received during childhood. Examples include the MMR vaccine (for measles, mumps, and rubella), HPV (human papilloma virus), chickenpox, and hepatitis. Additional or earlier vaccinations may be recommended if you have certain medical problems, such as having an immune system weakened by illness or medications. New recommendations Mumps In recent years, cases of mumps have spiked...
Publication date: Available online 2 June 2020Source: The Journal of Foot and Ankle SurgeryAuthor(s): Sergio Agudiez Calvo, Jorge Ballesteros de Frutos, Héctor Raúl Cabezas García, Daniel Pecos Martin, Tomás Gallego Izquierdo
The United States should have 100 million doses of one candidate coronavirus vaccine by the end of the year, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases and a member of the White House Coronavirus Task Force, said Tuesday.
The Trump administration chose 5 companies as the most likely to produce a vaccine. The tally of new cases is rising in the U.S., partly because of expanded testing. Italy ends travel restrictions.
A senior U.S. Army vaccine researcher said on Tuesday it was reasonable to expect that some sort of coronavirus vaccine could be available to part of the U.S. population by the end of the year.Reuters Health Information
The DRC has reported nearly 3,200 cases of coronavirus and 72 deaths and nearly 370,000 cases of measles with nearly 6,800 deaths since 2019, CNN reported.
This study aimed to analyze clinical and laboratory parameters and their association with long-term outcomes in patients who underwent liver transplantation for hepatocellular carcinoma treatment, according to the etiology of the underlying chronic liver disease, in order to identify predictors of response to this therapeutic modality. METHODS: Demographic, clinical, and laboratory data from a cohort of 134 patients who underwent orthotopic liver transplantation for hepatocellular carcinoma treatment at a referral center in Brazil were retrospectively selected and compared according to the etiologic group of the underlying...
At least two U.S. senators have said China hid data from the World Health Organization that could have altered the course of the coronavirus outbreak
The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
The Trump administration has selected five companies, including Moderna Inc, AstraZeneca Plc and Pfizer Inc, as the most likely candidates to produce a vaccine for the novel coronavirus, the New York Times reported on Wednesday, citing senior officials.
Publication date: Available online 2 June 2020Source: Hepatobiliary &Pancreatic Diseases InternationalAuthor(s): Xin Jin, Bin Fu, Zheng-Jie Wu, Xiao-Qin Zheng, Jian-Hua Hu, Lin-Feng Jin, Ling-Ling Tang
More News: Bacterial Pneumonia | Blogging | Brain | Cervical Cancer Vaccine | Chickenpox | Children | Chronic Pain | Computers | Cough | Encephalitis | Eyes | Graduation | Harvard | Health Insurance | Hepatitis | Hepatitis Vaccine | Human Papillomavirus (HPV) | Infectious Diseases | Influenza | Influenza Vaccine | Insurance | International Medicine & Public Health | Itchiness | Measles | Measles Vaccine | Meningitis Vaccine | Mumps | Mumps Vaccine | Neurology | Outbreaks | Pain | Pneomococcal Vaccine | Pneumonia | Polio | Polio Vaccine | Primary Care | Profits and Losses | Rubella | Rubella Vaccine | Shingles | Shingles (Herpes Zoster) Vaccine | Skin | Sports Medicine | Students | Tetanus | Tetanus Vaccine | Universities & Medical Training | Vaccines | Whooping Cough | Whooping Cough (Pertussis) Vaccine